参考文献
[1] Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description[J]. Circulation, 2002,106(24):3006⁃3008.
[2] Thyregod HG, Steinbrüchel DA, Ihlemann N, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1⁃year results from the all⁃comers NOTION
randomized clinical trial[J]. J Am Coll Cardiol, 2015, 65(20): 184⁃2194. DOI: 10.1016/j.jacc.2015.03.014.
[3] Mas⁃Peiro S, Vasa⁃Nicotera M, Weiler H, et al. Thirty⁃day outcomes in 100 consecutive patients undergoing transfemoral aortic valve replacement with the portico valve on an all⁃comer basis[J].J Invasive Cardiol, 2017,29(12):431⁃436.
[4] Nishimura RA, Otto CM, Bonow RO, et al2017 AHA / ACC focused update of the 2014 AHA / ACC guideline for the management of patients with valvular heart disease: a report of the American college of cardiology/American heart association task force on clinical practice guidelines[J].J Am Coll Cardiol, 2017,70(2):252⁃289. DOI: 10.1016/j.jacc.2017.03.011.
[5] Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC / EACTS Guidelines for the management of valvular heart disease[J].Eur Heart J, 2017, 38(36): 2739⁃2791. DOI: 10.1016 / j. rec. 2017. 12.013.
[6] Thourani VH, Suri RM, Gunter RL, et al. Contemporary real⁃world outcomes of surgical aortic valve replacement in 141, 905 low⁃risk, intermediate⁃risk, and high⁃risk patients[J]. Ann Thorac Surg, 2015, 99(1): 55⁃61. DOI: 10.1016 / j. athoracsur. 2014.06.050.
[7] Lars Sondergaard. Longevity of transcatheter and surgical bioprosthetic aortic valves in patients with severe aortic stenosis and lower surgical risk[EB/OL].(2018⁃05⁃25)[2018⁃07⁃01].https: //www. tctmd. com / slide / congevity⁃transcatheter⁃and⁃surgical⁃bioprosthetic⁃aortic⁃valves⁃patients⁃severe⁃aortic.
[8] Ron Waksman. Transcatheter aortic valve replacement for patients with severe aortic stenosis who are at low risk for mortality: interim results from the prospective multicenter LRT clinical trial[EB/OL].(2018⁃03⁃05)[2018⁃07⁃01].https://www.tctmd.com / search? rearched=true&type=slide&keyword=LRT&topic=&conference=&subtype=&page=1&year=&conferencebyyear=.
[9] 潘文志, 周达新, 葛均波. 经导管主动脉瓣置换术的中国现状2017[J]. 华西医学, 2018, 33(2): 132⁃136.DOI: 10.7505/1002⁃0179.201711135.
[10] El⁃Mawardy M, Wübken⁃Kleinfeld N, Schwarz B, et al. Transcatheter aortic valve implantation in patients with severely reduced left ventricular systolic function: a single⁃center experience[J]. Clin Res Cardiol, 2014, 103(8): 621⁃630. DOI:10.1007/s00392⁃014⁃0691⁃5.
[11] Yoon SH, Bleiziffer S, De Backer O, et al. Outcomes in Transcatheter aortic valve replacement for bicuspid versus tricuspid aortic valve stenosis[J]. J Am Coll Cardiol, 2017, 69(21):2579⁃2589.DOI:10.1016/j.jacc.2017.03.017.
[12] Liu XB, Jiang JB, Zhou QJ,et al.Evaluation of the safety and efficacy of transcatheter aortic valve implantation in patients with a severe stenotic bicuspid aortic valve in a Chinese population[J]. J Zhejiang Univ Sci B, 2015, 16(3): 208⁃14. DOI:10.1631/jzus.B1500017.
[13] Xiong TY, Zheng MX, Wei X,et al. Hemodynamic changes after transcatheter aortic valve implantation during sequential follow⁃ups in patients with bicuspid aortic valve compared with
tricuspid aortic valve[J]. Cardiol J, 2017, 24(4): 350⁃357. DOI:10.5603/CJ.a2017.0020.
[14] 中国医师协会心血管分会结构性心脏病专业委员会，中华医学会心血管分会结构性心脏病学组. 经导管主动脉瓣置换术中国专家共识[J]. 中国介入心脏病学杂志，2015,23（12）：661⁃667. DOI: 10.3969/j.issn.1004⁃8812.2015.12.001.
[15] Yoon SH, Schmidt T, Bleiziffer S, et al. Transcatheter aortic valve replacement in pure native aortic valve regurgitation[J].J Am Coll Cardiol, 2017, 70(22): 2752⁃2763. DOI: 10.1016 / j.jacc.2017.10.006.
[16] Zhu L, Guo Y, Wang W,et al. Transapical transcatheter aortic valve replacement with a novel transcatheter aortic valve replacement system in high⁃risk patients with severe aortic valve diseases[J].J Thorac Cardiovasc Surg,2018,155(2):588⁃597. DOI:10.1016/j.jtcvs.2017.09.015.
[17] Xiong TY, Feng Y, Liao YB, et al. Transcatheter aortic valve replacement in patients with non⁃calcific aortic stenosis[J]. EuroIntervention, 2018, 13(15): e1756⁃e1763. DOI: 10.4244 /EIJ⁃D⁃17⁃00584.
[18] Ye J, Lee AJ, Blanke P,et al. The first transapical transcatheter aortic valve⁃in⁃valve implantation using the J⁃valve system into a failed biophysio aortic prosthesis in a patient with high risk of coronary obstruction[J].Catheter Cardiovasc Interv,2018 [Epub ahead of print].DOI: 10.1002/ccd.27604.
[19] Généreux P, Stone GW, O'Gara PT, et al. Natural history, diagnostic approaches, and therapeutic strategies for patients with asymptomatic severe aortic stenosis[J]. J Am Coll Cardiol, 2016,67(19):2263⁃2288.DOI: 10.1016/j.jacc.2016.02.057.
